Clodronate for Treating High Calcium Levels in Cancer Patients
Author Information
Author(s): R.C. Percival, A.D. Paterson, A.J.P. Yates, D.J. Beard, D.L. Douglas, F.E. Neal, R.G.G. Russell, J.A. Kanis
Primary Institution: University of Sheffield Medical School
Hypothesis
Can clodronate effectively reduce serum calcium levels in patients with hypercalcaemia due to carcinoma?
Conclusion
Clodronate effectively reduced serum calcium and bone resorption in patients with hypercalcaemia due to carcinoma.
Supporting Evidence
- Clodronate reduced serum calcium in 14 out of 17 episodes studied.
- Bone resorption was suppressed in all patients during treatment.
- Normal serum calcium levels were observed in 9 patients after treatment.
Takeaway
Clodronate is a medicine that helps lower high calcium levels in people with cancer, making them feel better.
Methodology
The study involved 17 episodes of hypercalcaemia in 15 patients treated with clodronate for up to 3 months, measuring serum calcium and urinary calcium levels.
Potential Biases
Potential bias due to the lack of randomization and the small number of participants.
Limitations
The study had a small sample size and some patients did not respond to treatment.
Participant Demographics
15 patients (9 women and 6 men) with disseminated carcinoma.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website